Analysis of candidate genes in CRC patients' samples previously indicated that acquired resistance to EGFR blockade is associated with the emergence of clones carrying oncogenic mutations in the EGFR-RAS signalling axis16, 17, 26, 27, 28, 29. The gene discussed is EGFR; the disease is colorectal carcinoma.